Clinical Trial Update: 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

Phase 3 trial comparing GSK573719/GW642444 with GW642444 and with tiotropium in chronic obstructive pulmonary disease has completed; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK573719/GW642444 (GSK573719)
• GW642444 (GW642444)
• tiotropium (tiotropium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED | Results posted: 2014-02-10